Literature DB >> 33206218

miR-29a is a negative regulator of influenza virus infection through targeting of the frizzled 5 receptor.

Xiaoyun Yang1,2, Yurong Liang1,2, Gayan Bamunuarachchi1,2, Yanzhao Xu1,2, Kishore Vaddadi1,2, Samuel Pushparaj1,2, Dao Xu1,2, Zhengyu Zhu1,2, Rachel Blaha2, Chaoqun Huang1,2, Lin Liu3,4.   

Abstract

Influenza A virus (IAV) infections result in a large number of deaths and substantial economic losses each year. MicroRNAs repress gene expression and are involved in virus-host interactions. miR-29a is known to have anti-tumor and anti-fibrotic effects. However, the role of miR-29a in IAV infection is unclear. In the present study, we investigated the effect of miR-29a on IAV infection and the mechanisms by which it functions. IAV infection was found to cause decreased miR-29a expression in lung epithelial A549 cells and mouse lungs. Overexpression of miR-29a reduced IAV mRNA and protein levels and progeny virus production in HEK293 and A549 cells. Inhibition of IAV infection by miR-29a was observed with different strains of IAV, including A/PR/8/34, A/WSN/1933, and clinical isolates A/OK/3052/09 and A/OK/309/06 H3N2. Knockout of miR-29a using CRISPR/Cas9 resulted in an increase in viral mRNA and protein levels, confirming that miR-29a suppresses IAV infection. A 3' untranslated region (3'-UTR) reporter assay showed that miR-29a had binding sites in the 3'-UTR of the Wnt-Ca2+ signaling receptor frizzled 5 gene, and overexpression of miR-29a reduced the level of the endogenous frizzled 5 protein. Wnt5a treatment of HEK293 and A549 cells enhanced IAV infection. Our results suggest that miR-29a inhibits IAV infection, probably via the frizzled 5 receptor.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33206218      PMCID: PMC8075052          DOI: 10.1007/s00705-020-04877-z

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  63 in total

1.  Serial evaluation of high-resolution CT findings in patients with pneumonia in novel swine-origin influenza A (H1N1) virus infection.

Authors:  P Li; J-F Zhang; X-D Xia; D-J Su; B-L Liu; D-L Zhao; Y Liu; D-H Zhao
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

2.  Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection.

Authors:  Jiali Fang; Qian Hao; Li Liu; Yongkui Li; Jianguo Wu; Xixiang Huo; Ying Zhu
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  Preliminary microRNA analysis in lung tissue to identify potential therapeutic targets against H5N1 infection.

Authors:  James V Rogers; Jennifer A Price; Morgan Q S Wendling; James P Long; Herbert S Bresler
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

4.  Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA.

Authors:  Xiaoyang Zhang; Chunyan Dong; Xiaoning Sun; Zhongyi Li; Maolin Zhang; Zhenhong Guan; Ming Duan
Journal:  Biochem Biophys Res Commun       Date:  2014-06-19       Impact factor: 3.575

5.  Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus.

Authors:  M Kühl; L C Sheldahl; C C Malbon; R T Moon
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

6.  Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

Authors:  J S Nguyen-Van-Tam; P J M Openshaw; A Hashim; E M Gadd; W S Lim; M G Semple; R C Read; B L Taylor; S J Brett; J McMenamin; J E Enstone; C Armstrong; K G Nicholson
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

7.  Lung-Derived Exosomal miR-483-3p Regulates the Innate Immune Response to Influenza Virus Infection.

Authors:  Tadashi Maemura; Satoshi Fukuyama; Yukihiko Sugita; Tiago J S Lopes; Tomomi Nakao; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2018-04-11       Impact factor: 5.226

8.  The microRNA miR-485 targets host and influenza virus transcripts to regulate antiviral immunity and restrict viral replication.

Authors:  Harshad Ingle; Sushil Kumar; Ashwin Ashok Raut; Anamika Mishra; Diwakar Dattatraya Kulkarni; Takeshi Kameyama; Akinori Takaoka; Shizuo Akira; Himanshu Kumar
Journal:  Sci Signal       Date:  2015-12-08       Impact factor: 8.192

9.  MicroRNA expression and virulence in pandemic influenza virus-infected mice.

Authors:  Yu Li; Eric Y Chan; Jiangning Li; Chester Ni; Xinxia Peng; Elizabeth Rosenzweig; Terrence M Tumpey; Michael G Katze
Journal:  J Virol       Date:  2010-01-13       Impact factor: 5.103

10.  miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns.

Authors:  Eleni Bibaki; Eliza Tsitoura; Eirini Vasarmidi; George Margaritopoulos; Athina Trachalaki; Chara Koutoulaki; Theodora Georgopoulou; Demetrios A Spandidos; Nikos Tzanakis; Katerina M Antoniou
Journal:  Mol Med Rep       Date:  2018-03-19       Impact factor: 2.952

View more
  4 in total

1.  Analysis of MicroRNA Expression in Tears of Patients with Herpes Epithelial Keratitis: A Preliminary Study.

Authors:  Yu Jeong Kim; Yeji Yeon; Won June Lee; Yong Un Shin; Heeyoon Cho; Han Woong Lim; Min Ho Kang
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-04-01       Impact factor: 4.925

2.  miR-520a-5p regulates Frizzled 9 expression and mediates effects of cigarette smoke and iloprost chemoprevention.

Authors:  A J Smith; P Do; K Sompel; A Elango; M A Tennis
Journal:  Sci Rep       Date:  2022-02-11       Impact factor: 4.379

3.  Regulation of influenza A virus infection by Lnc-PINK1-2:5.

Authors:  Samuel Pushparaj; Zhengyu Zhu; Chaoqun Huang; Sunil More; Yurong Liang; Kong Lin; Kishore Vaddadi; Lin Liu
Journal:  J Cell Mol Med       Date:  2022-02-24       Impact factor: 5.310

Review 4.  Host Non-Coding RNA Regulates Influenza A Virus Replication.

Authors:  Yuejiao Liao; Shouqing Guo; Geng Liu; Zhenyu Qiu; Jiamin Wang; Di Yang; Xiaojing Tian; Ziling Qiao; Zhongren Ma; Zhenbin Liu
Journal:  Viruses       Date:  2021-12-29       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.